The objective of this study is to evaluate the clinical characteristics and outcomes of critically ill patients with COVID-19 admitted to the intensive care unit. A Multicenter Observational Study.
As of 23 March 2020, a cumulative total of 332,930 confirmed cases of coronavirus disease
2019 (COVID-19) were reported in 189 countries and territories worldwide. As of this time,
there had been 367 total confirmed cases of COVID-19, including four deaths in Mexico. The
clinical manifestations of patients with COVID-19 are wide, asymptomatic infection, mild
upper respiratory tract illness, and approximately 5% of critically ill patients with
COVID-19 have presented rapidly progressive respiratory failure, development of acute
respiratory distress syndrome (ARDS), and intensive care unit (ICU) admission. On March 24,
2020, the Secretary of Health of Mexico, formally declared the beginning of phase 2. It has
been estimated that many confirmed cases of COVID-19 would occur, thus would result in a
significant increase of hospital and ICU admissions.
Inclusion Criteria:
- Confirmed case: Critically ill patient who meets the operational definition of a
suspected case and who has a confirmed diagnosis by the National Network of Public
Health Laboratories recognized by the Institute of Epidemiological Diagnosis and
Reference (Indre) (Mexico).
Exclusion Criteria:
- If a negative for SARS-CoV-2 result is obtained from a critically ill patient with a
high index of suspicion for COVID-19 virus infection.
- Patients who had participated in another observational study in the last 30 days prior
to inclusion.
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
Mexico City, Mexico
All centres from Mexico willing to contribute are Welcome.
Mexico, Mexico